Q: Hello, I am thinking of selling Great West (GWO) and replacing it with a US life insurance company such as Metlife or Aflac. Does this make sense? Is there a better name in the US? I already own SLF. Thanks, Gervais
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Could you please give an update on your view of Helius.Thanks.
Q: MDT seems to be a bit of a rollercoaster but has a new valve device. What do you think of this company compared some other big device companies likes Stryker and are some device makers safe from Amazon's newest venture?
Q: Hello team,
What would you suggest for water and solar themes. I have looked at XYL and SolarEdge (SEDG). I am looking for GREAT companies with low debt and good management and positive shareholder history. What do you think of these two companies. I welcome any other suggestion you might have for better plays out there and for a very long term hold.
Thanks a lot as always for your great work.
What would you suggest for water and solar themes. I have looked at XYL and SolarEdge (SEDG). I am looking for GREAT companies with low debt and good management and positive shareholder history. What do you think of these two companies. I welcome any other suggestion you might have for better plays out there and for a very long term hold.
Thanks a lot as always for your great work.
Q: For increased international exposure I’m thinking of either VDU or VXUS. To buy VXUS, I would need to convert $C to $US. I currently have approximately 24% of my portfolio in $US, and this conversion would increase that to 28% or so. Which option do you think I should choose?
Q: After today's vote,I will reluctantly own some mty.Your opinion of mty and perhaps a few better suggestions if I sell.Sector and income are of no consideration.Thanks.
Q: It seems like there has been a significant amount of management selling ... can you please comment
Q: This is a followup to your answer to a question about this company on Feb 1, when you said you would hold off for now. If you owned the stock would you sell it?
Q: What is the strategy for this stock? Why has it sold off so much?
Q: this morning GUD stated that it submitted a new drug for review,Why it dropped sharply today?.Txs for u usual great services & response
Q: Hi Peter and Staff
So your growth portfolio results for February will show a disposition of these two stocks at yesterday's close - with yesterday's volume - there is zero chance we get out today or anytime soon at what you did / are these two companies going to survive or should we take what we get and exit ?
Thank you
Dennis
So your growth portfolio results for February will show a disposition of these two stocks at yesterday's close - with yesterday's volume - there is zero chance we get out today or anytime soon at what you did / are these two companies going to survive or should we take what we get and exit ?
Thank you
Dennis
Q: SNY (not in your database) recently reported a poor quarter and so-so guidance. On the other hand, the P/E is now less than 12x, the dividend is substantial, and the pipeline should be broad enough to protect against single-drug risk. My sense is that it's long-term-investable, but less attractive than other beaten-down pharma blue-chips (say, LLY); your opinion?
Q: Please comment on recently announced results.
Q: Regarding utilities falling prices, you have answered in a couple times in the Q&A: "The main issue is that US tax reform is going to reduce earnings due to lower tax recoveries." Can you expand on this? What is the percentage of reduction? I looked for an article and couldn't find one explaining this. I am looking to add to AQN, FTS and BEP.UN for their growing yield, but I can't determine a fair price or if they're under/over valued because of the US tax reform and am hoping you can help me make my decision. Thanks
Q: Good morning,
I notice in today's Q&A you mention the addition to Reliq Healthcare to one of your portfolios. When such changes are made to portfolios, are the intra-month additions and deletions announced somewhere on the site, or only visible in the month end portfolio update publications?
Also, can you comment on Reliq's patient onboarding process. In your view, are there risks with this process (delays on big contracts) or with a large competitor entering the space.
Thank you
I notice in today's Q&A you mention the addition to Reliq Healthcare to one of your portfolios. When such changes are made to portfolios, are the intra-month additions and deletions announced somewhere on the site, or only visible in the month end portfolio update publications?
Also, can you comment on Reliq's patient onboarding process. In your view, are there risks with this process (delays on big contracts) or with a large competitor entering the space.
Thank you
Q: I just read a contrarian report on Seeking Alpha regarding these two companies. Can you comment on the debt levels of each and their respective survivability in a prolonged long low price nat gas environment. In an RRSP, could they be considered decent ‘flyers’ for a small (1%) stake?
DON
DON
Q: Comments on earnings please.
Q: I would like to add one of these names to my tfsa any thoughts.
Q: I see you have removed SYZ from the balanced portfolio. As a thin trader, would you expect the stock to go down as some/many of your followers will 'rebalance' to match your moves? If it does move down, is this a lesson for subscribers to be careful in investing in recommendations that trade thinly? Of course, it works the other way when a thinly traded stock is first recommended.
- Invesco Aerospace & Defense ETF (PPA)
- iShares U.S. Aerospace & Defense ETF (ITA)
- SPDR S&P Aerospace & Defense ETF (XAR)
Q: Hi,
This is a follow up to your answer regarding my original question on Feb 14th regarding ETFs in the US Aerospace and Defense sector. Your answer focused my attention on the expense ratio as the main factor in choosing among ETFs with a similar theme, and you offered that 5 year average returns should also be considered. However, I am wondering if the dividends paid should also be a part of the decision? If yes, then as a general rule, ETF dividends would be considered only if all else is equal? Between the three ETFs, PPA pays .2504, XAR pays .0938 and ITA pays .3205. All are listed as quarterly payments. Thanks for helping out with my learning curve!
Dawn
This is a follow up to your answer regarding my original question on Feb 14th regarding ETFs in the US Aerospace and Defense sector. Your answer focused my attention on the expense ratio as the main factor in choosing among ETFs with a similar theme, and you offered that 5 year average returns should also be considered. However, I am wondering if the dividends paid should also be a part of the decision? If yes, then as a general rule, ETF dividends would be considered only if all else is equal? Between the three ETFs, PPA pays .2504, XAR pays .0938 and ITA pays .3205. All are listed as quarterly payments. Thanks for helping out with my learning curve!
Dawn